Target intelligence / Profile preview

Oxidative stress regulatory proteins

Molecular classification
Enzyme, Transcription factor, Transporter, Other
01

Overview

Oxidative stress regulatory proteins are a broad class of molecules, including enzymes and transcription factors, that maintain cellular redox balance by managing reactive oxygen species (ROS) (Ighodaro & Akinloye, 2018, PMID: 29473213). Key members include superoxide dismutase (SOD), catalase, glutathione peroxidase, and the master transcriptional regulator Nuclear factor erythroid 2-related factor 2 (Nrf2) (He et al., 2020, PMID: 32165834). These proteins protect cells from oxidative damage to DNA, proteins, and lipids, which is a primary driver of aging and chronic diseases such as Parkinson's, Alzheimer's, and atherosclerosis (Sies et al., 2017, PMID: 28851513). In drug development, these proteins are targeted either to enhance antioxidant defenses, such as with Nrf2 activators like Dimethyl fumarate for multiple sclerosis, or to inhibit them in cancer to increase oxidative stress-induced apoptosis (Sayin et al., 2014, PMID: 24478344). However, the complexity of redox signaling poses challenges, as excessive antioxidant activity can sometimes interfere with normal physiological processes or promote the survival of malignant cells (Le Gal et al., 2015, PMID: 26446958).

Other names
Antioxidant defense proteinsRedox regulatory proteinsAntioxidant enzymesReactive oxygen species (ROS) regulatory proteins
02

Mechanism of action

Activation of the Nrf2-ARE signaling pathway to induce phase II antioxidant enzymes, direct scavenging of reactive oxygen species, and enzymatic neutralization of superoxide and hydrogen peroxide (He et al., 2020, PMID: 32165834; Ighodaro & Akinloye, 2018, PMID: 29473213).

03

Biological functions

Redox homeostasisDetoxificationCell survivalSignal transductionApoptosis
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseInflammationDiabetesAging
05

Safety considerations

Potential to promote survival of existing cancer cells (Sayin et al., 2014, PMID: 24478344)Interference with essential ROS-mediated signalingSystemic toxicity from broad redox modulationOff-target effects of electrophilic activators
06

Interacting drugs

N-acetylcysteine (NAC)

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH) levelsSuperoxide dismutase (SOD) activityProtein carbonyls

Beyond the preview

Go deeper on Oxidative stress regulatory proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidative stress regulatory proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call